C4- CFT7455-1102

Who Can Participate in the Study?

Age Group
Adults

Study Details

Full Title
A Phase 1b, Open-Label, Multicenter Study to Evaluate the Safety and Preliminary Efficacy of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma
Principal Investigator
Headshot of Cristina Gasparetto
Professor of Medicine
Protocol Number
IRB: PRO00119697
NCT: NCT07280013
Phase
Phase I
ClinicalTrials.gov
Enrollment Status
OPEN TO ACCRUAL